Abstract:Objective: To investigate the relationship between abnormal lymphocyte homing and colon lesions in ulcerative colitis. Methods: 60 Sprague-Dawley rats were randomly divided into 3 equal groups: model group [undergoing enema of dinitrochlorobenzene to establish models of ulcerative colitis and then venous injection of normal saline (NS) once a day for 5 days], lymphocyte homing intervention group [undergoing venous injection of secondary lymphoid-tissue chemokine (SLC) antibody, and then venous injection of NS for 5 days], and control group [undergoing venous injection of NS for 5 days]. On the 6th day blood samples were collected from the portal vein to isolated lymphocytes. Distant colon was dissected to undergo pathological examination of submucosal aggregated lymphatic follicles, ulceration, and inflammation, thus observing the lymphocyte homing situation. Specimens of colon mucosa underwent detection cytokine of interleukin (IL)-2 and IL-6. RT-PCR was used to detect the mRNA expression of SLC gene and the chemokine receptor CCR7. The proportion of CCR7 positive lymphocytes which drainage from colonic vein were measured by flow cytometry (FC). Results: Abnormal lymphocyte homing phenomenon under colonic mucosa was found in the model and intervention groups. The relative grey degree of SLC gene mRNA expression of the model and intervention groups were 0.85 ± 0.05 and 0.77 ± 0.14 respectively, both significantly higher than that of the control group (0.31 ± 0.11, both P < 0.01), however, without significant difference between the 2 former groups. The relative grey degree of CCR7 mRNA expression of the model group was 0.79 ± 0.11, significantly higher than that of the intervention groups (0.39 ± 0.12 P = 0.0429), and both were significantly higher than that of the control group (0.11 ± 0.03 both P < 0.01). FC showed that the proportion of CCR7+ lymphocytes drainage from colonic vein of the model and the intervention groups were 69% ± 5% and 77% ± 10% respectively, both significantly higher than that of the control group(17% ± 84%, both P < 0.01), however, without significant difference between these 2 former groups (P = 0.0837). Conclusion: Abnormal lymphocyte homing is associated with inflammation of the colonic mucosa. Blocking of the lymphocyte homing is effective in reducing the inflammation of colonic mucosa.

IL-6 deficiency promotes colitis by recruiting Ly6Chi monocytes into inflamed colon tissues in a CCL2-CCR2-dependent manner

IL-6 deficiency promotes colitis by recruiting Ly6C<SUP>hi</SUP> monocytes into inflamed colon tissues in a CCL2-CCR2-dependent manner

Deletion of IL-6 Exacerbates Colitis and Induces Systemic Inflammation in IL-10-Deficient Mice.

Fbxw7 Increases CCL2/7 in CX3CR1(hi) Macrophages to Promote Intestinal Inflammation

Role of IL-6 in the imbalance of Th17/Treg in DSS-induced ulcerative colitis mice

C-X-C Motif Chemokine Ligand 1 Promotes Colitis by Modulating the Gut Microbiota

Abnormal lymphocyte homing and colon lesions in ulcerative colitis: experiment with rats

Il-23 Is Highly Expressed In Inflammatory Bowel Disease And Induces T Cell Proinflammatory Cytokine Secretion

The effect of oral tolerance on the roles of small intestinal intraepithelial lymphocytes in murine colitis induced by dextran sodium sulfate

W1155 IL-21 Receptor Signaling Enhances NK Cell Cytolytic Activity and Induces Proinflammatory Cytokine Production in Inflammatory Bowel Disease

Transgenic Overexpression of ITGB6 in Intestinal Epithelial Cells Exacerbates Dextran Sulfate Sodium‐induced Colitis in Mice

Deletion of IL-6 in Dntgfβrii Mice Improves Colitis but Exacerbates Autoimmune Cholangitis (96.10)

Interleukin-6 absence triggers intestinal microbiota dysbiosis and mucosal immunity in mice

Deletion of IL-6 in dnTGF{beta}RII Mice Improves Colitis but Exacerbates Autoimmune Cholangitis

Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease

Complement Component 6 Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Murine Colitis.

Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice

Interleukin-6 Promotes Tumor Progression in Colitis-Associated Colorectal Cancer Through HIF-1α Regulation

Cytokine Il-6 is Required in Citrobacter Rodentium Infection-Induced Intestinal Th17 Responses and Promotes Il-22 Expression in Inflammatory Bowel Disease

Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis

Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis